Lab study reveals how tenofovir crosses the placenta
NCT ID NCT02020083
First seen Feb 18, 2026 · Last updated May 21, 2026 · Updated 8 times
Summary
This study looked at how the HIV drug tenofovir passes from mother to baby through the placenta. Researchers used a lab model with placentas from 369 healthy pregnant women to measure drug levels and gene activity. The goal was to understand what affects drug transfer, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANT WOMEN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Maternité de Port Royal
Paris, France
Conditions
Explore the condition pages connected to this study.